Literature DB >> 26112793

Draft Genome Sequence of the Streptococcus pneumoniae Avery Strain A66.

Christoph Hahn1, Ewan M Harrison2, Julian Parkhill3, Mark A Holmes2, Gavin K Paterson4.   

Abstract

We have used HiSeq 2000 technology to generate a draft genome sequence of Streptococcus pneumoniae strain A66. This is a common study strain used in investigations of pneumococcal bacterium-host interactions and was used in the seminal genetic studies of Avery et al.
Copyright © 2015 Hahn et al.

Entities:  

Year:  2015        PMID: 26112793      PMCID: PMC4481291          DOI: 10.1128/genomeA.00697-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Streptococcus pneumoniae is a prominent human pathogen throughout the world, particularly as a cause of pneumonia, meningitis, bacteremia, and otitis media. S. pneumoniae strain A66 (NCTC 7978) and derivatives, such as A66.1, are virulent in mice and have been used by many laboratories for in vivo studies examining host immune responses (1, 2), preclinical vaccination evaluation (3–5), the development of novel therapies (6, 7), studies on virulence mechanisms (8, 9), and the use of a bioluminescent form to track infection in vivo (10, 11). It has also been used in a variety of in vitro studies, notably including the work of Avery et al. (12). To facilitate the use of A66 as a study strain, we present here its draft genome sequence. DNA was harvested from a minimally passaged culture from the National Collection of Type Cultures, where the strain was deposited in 1949 from the Rockefeller Institute for Medical Research, and sequenced using Illumina HiSeq 2000 technology. Assembly was performed using Velvet software (13), and the assembled contigs were reordered and oriented by alignment using Mauve software (14) with S. pneumoniae OXC141 as a reference. The assembly consisted of 159 contigs, with an N50 of 53,248 bp. It was automatically annotated using RAST (15) and compared to strains TIGR4 and OXC141 using the Artemis Comparison Tool. The A66 draft genome was 1,983,415 bp in length with a GC content of 39.7%. Annotation found 2,087 coding sequences, including the genes for pneumolysin, the serotype 3 capsular locus, neuraminidase A, choline binding protein A, hyluronidase, ZmpA, and zinc metalloprotease B. However, A66 lacked the rlrA pilus locus, psrP locus, and zmpC. The genome-derived multilocus sequence type is ST387 (16). No acquired antimicrobial resistance genes were identified in the genome sequence using ResFinder version 2.1 (17), and the strain was phenotypically susceptible to all antibiotics tested using Vitek 2 (card AST-ST01). The availability of a draft genome sequence for A66 will greatly facilitate its value as a model strain for investigating pneumococcal biology.

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited in DDBJ/ENA/GenBank under the accession number LN847353. The version described in this paper is the first version, LN847353.1.
  17 in total

1.  Multilocus sequence typing of total-genome-sequenced bacteria.

Authors:  Mette V Larsen; Salvatore Cosentino; Simon Rasmussen; Carsten Friis; Henrik Hasman; Rasmus Lykke Marvig; Lars Jelsbak; Thomas Sicheritz-Pontén; David W Ussery; Frank M Aarestrup; Ole Lund
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

2.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

3.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

4.  The role of Streptococcus pneumoniae sortase A in colonisation and pathogenesis.

Authors:  Gavin K Paterson; Tim J Mitchell
Journal:  Microbes Infect       Date:  2005-08-10       Impact factor: 2.700

5.  Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease.

Authors:  Amit Srivastava; Heather Casey; Nathaniel Johnson; Ofer Levy; Richard Malley
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

6.  Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.

Authors:  M Yamamoto; L S McDaniel; K Kawabata; D E Briles; R J Jackson; J R McGhee; H Kiyono
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

7.  Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.

Authors:  Jenni N Weeks; Kelli L Boyd; Gowrisankar Rajam; Edwin W Ades; Jonathan A McCullers
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

8.  Organ-specific models of Streptococcus pneumoniae disease.

Authors:  Carlos J Orihuela; Geli Gao; Mackenzie McGee; Jun Yu; Kevin P Francis; Elaine Tuomanen
Journal:  Scand J Infect Dis       Date:  2003

9.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790

10.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

View more
  1 in total

1.  The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA.

Authors:  Kristopher R Genschmer; Cintia F M Vadesilho; Larry S McDaniel; Sang-Sang Park; Yvette Hale; Eliane N Miyaji; David E Briles
Journal:  mSphere       Date:  2019-12-11       Impact factor: 4.389

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.